Cite
APA Citation
Symonds, L., Yu, M., Zhang, Y., Ou, F., Zemla, T. J., Carter, K., Bertagnolli, M., Innocenti, F., Bosch, L. J., Meijer, G. A., Carvalho, B., Grady, W. M., & Cohen, S. A. (2022). evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance). Epigenetics, 17(12), 1715–1725. http://access.bl.uk/ark:/81055/vdc_100169176038.0x00001d